KATHERINE TOTTY: Open Payments
NPI 1164856894 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 41 payments from 12 companies in 2025. Trend: 2023 $1,183 · 2024 $1,603 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $152 |
| Merck Sharp & Dohme LLC | 7 | $139 |
| ABIOMED | 3 | $82 |
| Novo Nordisk Inc | 4 | $71 |
| Boston Scientific Corporation | 2 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Alnylam Pharmaceuticals Inc. | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| PFIZER INC. | 2 | $35 |
| Abbott Laboratories | 1 | $20 |
Products named: VERQUVO, LEQVIO, Wegovy, JARDIANCE, AMVUTTRA, PatientCare Link, ELIQUIS, CAMZYOS.
Industry payments across MS — which companies pay providers there.
